MDL3

MDL3 is a novel inhibitor of PDE4B and PDE5A. MDL3 against liver injury and inflammation and inhibits the pathological remodeling of adipose tissue[1].

Product Specifications

UNSPSC

12352005

Target

Phosphodiesterase (PDE)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/mdl3.html

Smiles

CC1=NC(NC2=CC=C(CC(O)=O)C=C2)=NC(NC3=CC=C(F)C(C(F)(F)F)=C3)=C1C

Molecular Formula

C21H18F4N4O2

Molecular Weight

434.39

References & Citations

[1]Dalton W Staller, ET AL. A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases. Hepatology. 2024 Jul 1.